|
Quotes & Info
|
| ENZN > SEC Filings for ENZN > Form 8-K on 30-Nov-2012 | All Recent SEC Filings |
30-Nov-2012
Other Events, Financial Statements and Exhibits
On November 29, 2012, Enzon Pharmaceuticals, Inc. issued a press release announcing that its board of directors authorized a special dividend of $2.00 per common share, payable on December 21, 2012 to shareholders of record as of December 10, 2012.
A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
(d) Exhibits
Exhibit
No. Description
99.1 Press Release of Enzon Pharmaceuticals, Inc. dated November 29, 2012
|
|